Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells (vol 240, pg 426, 2015)

被引：0
|
作者：
Huang, O.
Zhang, W.
Zhi, Q.
Xue, X.
Liu, H.
Shen, D.
Geng, M.
Xie, Z.
Jiang, M.
机构：
来源：
EXPERIMENTAL BIOLOGY AND MEDICINE | 2020年 / 245卷 / 03期
关键词：
D O I：
10.1177/1535370220901429
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：NP2 / NP2
页数：1
相关论文
共 50 条
  • [21] Activity of dasatinib with chemotherapy in triple-negative breast cancer cells
    Tryfonopoulos, D.
    O'Donovan, N.
    Corkery, B.
    Clynes, M.
    Crown, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] The Antioxidant Potential and Anticancer Activity of Halodule uninervis Ethanolic Extract against Triple-Negative Breast Cancer Cells
    Wehbe, Nadine
    Badran, Adnan
    Baydoun, Serine
    Al-Sawalmih, Ali
    Maresca, Marc
    Baydoun, Elias
    Mesmar, Joelle Edward
    ANTIOXIDANTS, 2024, 13 (06)
  • [23] A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells (vol 58, pg 6559, 2015)
    Fouque, Amelie
    Delalande, Olivier
    Jean, Mickael
    Castellano, Remy
    Josselin, Emmanuelle
    Malleter, Marine
    Shoji, Kenji F.
    Mac Dinh Hung
    Rampanarivo, Hariniaina
    Collette, Yves
    van de Weghe, Pierre
    Legembre, Patrick
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (20) : 9339 - 9340
  • [24] The Many Faces of Triple Negative Breast Cancer (vol 109, pg 471, 2014)
    Comanescu, M.
    Poteca, A.
    Cocosila, C.
    Poteca, T.
    CHIRURGIA, 2014, 109 (05)
  • [25] Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer
    Doddapaneni, Ravi
    Patel, Ketan
    Chowdhury, Nusrat
    Singh, Mandip
    EXPERIMENTAL CELL RESEARCH, 2016, 346 (01) : 65 - 73
  • [26] Anticancer activity of palladium-based complexes against triple-negative breast cancer
    Vojtek, Martin
    Marques, Maria P. M.
    Ferreira, Isabel M. P. L. V. O.
    Mota-Filipe, Helder
    Diniz, Carmen
    DRUG DISCOVERY TODAY, 2019, 24 (04) : 1044 - 1058
  • [27] Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells (vol 22, pg 820, 2015)
    Kim, Kyung-Ho
    Kim, Ji-Yun
    Kwak, Jong-Hwan
    Pyo, Suhkneung
    PHYTOMEDICINE, 2019, 61
  • [28] Combination of metformin and metronomic liposomal doxorubicin exerts a robust anticancer effect in triple negative breast cancer by inhibiting breast cancer stem cells & the Wnt/beta-catenin pathway
    Banerjee, Indranil
    Das, Subhayan
    Das, Chandan Kanta
    Jena, Bikash Ch
    Bharadwaj, Deblina
    Pradhan, Anjan K.
    Das, Swadesh K.
    Fisher, Paul B.
    Mandel, Mahitosh
    CANCER RESEARCH, 2019, 79 (13)
  • [29] New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells (vol 39, pg 241, 2020)
    Ciocan-Cartita, Cristina Alexandra
    Jurj, Ancuta
    Zanoaga, Oana
    Cojocneanu, Roxana
    Pop, Laura-Ancuta
    Moldovan, Alin
    Moldovan, Cristian
    Zimta, Alina Andreea
    Raduly, Lajos
    Pop-Bica, Cecilia
    Buse, Mihail
    Budisan, Liviuta
    Virag, Piroska
    Irimie, Alexandru
    Gomes Dias, Sandra Martha
    Berindan-Neagoe, Ioana
    Braicu, Cornelia
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [30] Quantitative Phosphoproteomics and Acetylomics of Safranal Anticancer Effects in Triple-Negative Breast Cancer Cells
    Ashrafian, Shahrbanou
    Zarrineh, Mahshid
    Jensen, Pia
    Nawrocki, Arkadiusz
    Rezadoost, Hassan
    Ansari, Alireza Madjid
    Farahmand, Leila
    Ghassempour, Alireza
    Larsen, Martin R.
    JOURNAL OF PROTEOME RESEARCH, 2022, : 2566 - 2585
12345